

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.12030901 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99949845 |
| 3 | regulation of early endosome to late endosome transport (GO:2000641) | 3.87586816 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.70620942 |
| 5 | stress fiber assembly (GO:0043149) | 3.68602807 |
| 6 | barbed-end actin filament capping (GO:0051016) | 3.55904534 |
| 7 | negative regulation of cell size (GO:0045792) | 3.40685617 |
| 8 | protein retention in ER lumen (GO:0006621) | 3.35273605 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.29659428 |
| 10 | skin morphogenesis (GO:0043589) | 3.22460182 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10940571 |
| 12 | negative regulation of necrotic cell death (GO:0060547) | 3.05519894 |
| 13 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02983513 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 3.01073692 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.01073692 |
| 16 | positive regulation of protein dephosphorylation (GO:0035307) | 2.98977166 |
| 17 | response to peptidoglycan (GO:0032494) | 2.95381775 |
| 18 | modulation by symbiont of host cellular process (GO:0044068) | 2.86805786 |
| 19 | regulation of extracellular matrix disassembly (GO:0010715) | 2.85033534 |
| 20 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.84166553 |
| 21 | positive regulation of fibroblast migration (GO:0010763) | 2.82843270 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 2.82559955 |
| 23 | virion attachment to host cell (GO:0019062) | 2.82559955 |
| 24 | signal complex assembly (GO:0007172) | 2.78923754 |
| 25 | focal adhesion assembly (GO:0048041) | 2.77780677 |
| 26 | cell-substrate adherens junction assembly (GO:0007045) | 2.77780677 |
| 27 | regulation of necrotic cell death (GO:0010939) | 2.77400039 |
| 28 | pinocytosis (GO:0006907) | 2.76263221 |
| 29 | adherens junction assembly (GO:0034333) | 2.75862928 |
| 30 | positive regulation of receptor recycling (GO:0001921) | 2.75816718 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74524693 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74524693 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 2.74524693 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74524693 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 2.74524693 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74524693 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74280131 |
| 38 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.72004404 |
| 39 | protein targeting to plasma membrane (GO:0072661) | 2.69726065 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.65995448 |
| 41 | activation of Rac GTPase activity (GO:0032863) | 2.61480549 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.60860328 |
| 43 | negative regulation of cell killing (GO:0031342) | 2.60860328 |
| 44 | adhesion of symbiont to host (GO:0044406) | 2.60323659 |
| 45 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.58860422 |
| 46 | cell-substrate junction assembly (GO:0007044) | 2.58424196 |
| 47 | modulation by virus of host process (GO:0019054) | 2.57323947 |
| 48 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.57036190 |
| 49 | mannose metabolic process (GO:0006013) | 2.56947272 |
| 50 | positive regulation of extracellular matrix organization (GO:1903055) | 2.56800496 |
| 51 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56256929 |
| 52 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.52985052 |
| 53 | negative regulation of necroptotic process (GO:0060546) | 2.52576359 |
| 54 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.52276163 |
| 55 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51509686 |
| 56 | regulation of macrophage cytokine production (GO:0010935) | 2.50615605 |
| 57 | adenosine receptor signaling pathway (GO:0001973) | 2.49705356 |
| 58 | cortical actin cytoskeleton organization (GO:0030866) | 2.48413554 |
| 59 | regulation of ARF protein signal transduction (GO:0032012) | 2.48408794 |
| 60 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46511136 |
| 61 | activation of MAPKKK activity (GO:0000185) | 2.45737506 |
| 62 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.45483863 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45239399 |
| 64 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.44575694 |
| 65 | response to laminar fluid shear stress (GO:0034616) | 2.44273635 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.43111517 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41065105 |
| 68 | peptidyl-proline hydroxylation (GO:0019511) | 2.40865936 |
| 69 | endocytic recycling (GO:0032456) | 2.38262367 |
| 70 | hypotonic response (GO:0006971) | 2.37800299 |
| 71 | extracellular fibril organization (GO:0043206) | 2.36915284 |
| 72 | fibril organization (GO:0097435) | 2.34657964 |
| 73 | cell-cell junction maintenance (GO:0045217) | 2.34160110 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.33922410 |
| 75 | regulation of response to osmotic stress (GO:0047484) | 2.33666875 |
| 76 | glutamate secretion (GO:0014047) | 2.33613656 |
| 77 | hyaluronan catabolic process (GO:0030214) | 2.32342812 |
| 78 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.32180335 |
| 79 | positive regulation of macrophage cytokine production (GO:0060907) | 2.31682814 |
| 80 | UV protection (GO:0009650) | 2.30462215 |
| 81 | substrate-dependent cell migration (GO:0006929) | 2.30024048 |
| 82 | synaptic vesicle exocytosis (GO:0016079) | 2.29875953 |
| 83 | response to host defenses (GO:0052200) | 2.29445865 |
| 84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.29445865 |
| 85 | response to host (GO:0075136) | 2.29445865 |
| 86 | macrophage activation involved in immune response (GO:0002281) | 2.29279240 |
| 87 | endodermal cell differentiation (GO:0035987) | 2.29247273 |
| 88 | platelet aggregation (GO:0070527) | 2.28776805 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.26995837 |
| 90 | regulation of leukocyte degranulation (GO:0043300) | 2.26532339 |
| 91 | protein maturation by protein folding (GO:0022417) | 2.22633335 |
| 92 | regulation of protein dephosphorylation (GO:0035304) | 2.22142978 |
| 93 | regulation of ARF GTPase activity (GO:0032312) | 2.21715067 |
| 94 | modulation by virus of host morphology or physiology (GO:0019048) | 2.21572239 |
| 95 | protein hydroxylation (GO:0018126) | 2.21269617 |
| 96 | cortical cytoskeleton organization (GO:0030865) | 2.20122096 |
| 97 | pentose-phosphate shunt (GO:0006098) | 2.18775272 |
| 98 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.18648443 |
| 99 | positive regulation of myotube differentiation (GO:0010831) | 2.17793280 |
| 100 | actin filament bundle organization (GO:0061572) | 2.17178853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.32023642 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.27657256 |
| 3 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.96908845 |
| 4 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.82203016 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55312840 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.46914561 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42857227 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33542410 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19836081 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18676295 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18049811 |
| 12 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.15729343 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09175779 |
| 14 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.05699509 |
| 15 | KDM2B_26808549_Chip-Seq_K562_Human | 1.89994013 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 1.89390777 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85830098 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.82951869 |
| 19 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82588314 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76132378 |
| 21 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.73511374 |
| 22 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.68273131 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67809611 |
| 24 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.65053489 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61450058 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61373551 |
| 27 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.60345617 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59859134 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59368888 |
| 30 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59209507 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57333772 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56276812 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55333909 |
| 34 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54174296 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.53010740 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52509554 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.51897465 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45221141 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44459496 |
| 40 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43146250 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42678784 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41926856 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.39312498 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38429892 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37952583 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36882261 |
| 47 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36639313 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35554103 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34785968 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33294404 |
| 51 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33211280 |
| 52 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32647887 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31313171 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29873397 |
| 55 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29548773 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28229609 |
| 57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28194871 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28193093 |
| 59 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.27963932 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.27296562 |
| 61 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26899964 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26721686 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25727617 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25313559 |
| 65 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.24092821 |
| 66 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23179972 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22779033 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21577439 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20130401 |
| 70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19681395 |
| 71 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19397642 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19264016 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18302853 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17826192 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17803640 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15922690 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15545957 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14616398 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13733311 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13606002 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12665729 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12306163 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11703652 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11219441 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10163400 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08207301 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07907688 |
| 88 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07450676 |
| 89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06587183 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06478350 |
| 91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05150619 |
| 92 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05112271 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04887169 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04018861 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.02789543 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00449743 |
| 97 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98298012 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98147981 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96254025 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95951955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.27953911 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.27537799 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.19259784 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.02973727 |
| 5 | MP0009840_abnormal_foam_cell | 2.74342768 |
| 6 | MP0005451_abnormal_body_composition | 2.71528242 |
| 7 | MP0004510_myositis | 2.65196718 |
| 8 | MP0003436_decreased_susceptibility_to | 2.56176575 |
| 9 | MP0003279_aneurysm | 2.51952400 |
| 10 | MP0003303_peritoneal_inflammation | 2.42742642 |
| 11 | MP0009278_abnormal_bone_marrow | 2.41952887 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.34761778 |
| 13 | MP0001958_emphysema | 2.25072767 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.24787386 |
| 15 | MP0004858_abnormal_nervous_system | 2.20869911 |
| 16 | MP0000751_myopathy | 2.17209234 |
| 17 | MP0008260_abnormal_autophagy | 2.07213172 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.04049209 |
| 19 | MP0003329_amyloid_beta_deposits | 1.85264683 |
| 20 | MP0005623_abnormal_meninges_morphology | 1.84615290 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.83953722 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.79127243 |
| 23 | MP0003075_altered_response_to | 1.76841334 |
| 24 | MP0003091_abnormal_cell_migration | 1.71847313 |
| 25 | MP0001849_ear_inflammation | 1.69107088 |
| 26 | MP0005023_abnormal_wound_healing | 1.66308755 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.59688999 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.56367517 |
| 29 | MP0004272_abnormal_basement_membrane | 1.56059732 |
| 30 | MP0000858_altered_metastatic_potential | 1.55543944 |
| 31 | MP0000343_altered_response_to | 1.49485710 |
| 32 | MP0001542_abnormal_bone_strength | 1.46709602 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.39605008 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.37975162 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.37975162 |
| 36 | MP0004947_skin_inflammation | 1.36970871 |
| 37 | MP0002419_abnormal_innate_immunity | 1.33565693 |
| 38 | MP0000604_amyloidosis | 1.33021331 |
| 39 | MP0003879_abnormal_hair_cell | 1.31800226 |
| 40 | MP0000759_abnormal_skeletal_muscle | 1.27522764 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.25503550 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.24739049 |
| 43 | MP0006082_CNS_inflammation | 1.23147848 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.21999410 |
| 45 | MP0005390_skeleton_phenotype | 1.20775530 |
| 46 | MP0000749_muscle_degeneration | 1.20413564 |
| 47 | MP0003828_pulmonary_edema | 1.20019797 |
| 48 | MP0005275_abnormal_skin_tensile | 1.16423107 |
| 49 | MP0003724_increased_susceptibility_to | 1.15320730 |
| 50 | MP0005025_abnormal_response_to | 1.14045948 |
| 51 | MP0000767_abnormal_smooth_muscle | 1.12054256 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.11672858 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.09404557 |
| 54 | MP0000920_abnormal_myelination | 1.06508195 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.05681296 |
| 56 | MP0008874_decreased_physiological_sensi | 1.05555292 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.05319758 |
| 58 | MP0000747_muscle_weakness | 1.03082669 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.02322427 |
| 60 | MP0005166_decreased_susceptibility_to | 1.01713148 |
| 61 | MP0003634_abnormal_glial_cell | 1.01280501 |
| 62 | MP0008004_abnormal_stomach_pH | 0.99529510 |
| 63 | MP0002060_abnormal_skin_morphology | 0.99300139 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.98916642 |
| 65 | MP0005375_adipose_tissue_phenotype | 0.98752029 |
| 66 | MP0005164_abnormal_response_to | 0.97849047 |
| 67 | MP0000685_abnormal_immune_system | 0.97829353 |
| 68 | MP0005666_abnormal_adipose_tissue | 0.97139376 |
| 69 | MP0003448_altered_tumor_morphology | 0.96548105 |
| 70 | MP0000003_abnormal_adipose_tissue | 0.96279640 |
| 71 | MP0000733_abnormal_muscle_development | 0.94521410 |
| 72 | MP0004233_abnormal_muscle_weight | 0.94127103 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 0.93723090 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 0.93280117 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 0.92759330 |
| 76 | MP0005165_increased_susceptibility_to | 0.92019369 |
| 77 | MP0009384_cardiac_valve_regurgitation | 0.91240522 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.90414312 |
| 79 | MP0005595_abnormal_vascular_smooth | 0.87124576 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.86667602 |
| 81 | MP0003690_abnormal_glial_cell | 0.85193281 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.83963636 |
| 83 | MP0004087_abnormal_muscle_fiber | 0.82134275 |
| 84 | MP0002933_joint_inflammation | 0.81521197 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.80650061 |
| 86 | MP0005387_immune_system_phenotype | 0.80462246 |
| 87 | MP0001790_abnormal_immune_system | 0.80462246 |
| 88 | MP0001851_eye_inflammation | 0.78926102 |
| 89 | MP0008569_lethality_at_weaning | 0.78000124 |
| 90 | MP0003795_abnormal_bone_structure | 0.75869208 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.75376152 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.74737682 |
| 93 | MP0009785_altered_susceptibility_to | 0.74476343 |
| 94 | MP0005621_abnormal_cell_physiology | 0.73609773 |
| 95 | MP0005670_abnormal_white_adipose | 0.73154247 |
| 96 | MP0002723_abnormal_immune_serum | 0.65488906 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.64218590 |
| 98 | MP0001819_abnormal_immune_cell | 0.63774869 |
| 99 | MP0005409_darkened_coat_color | 0.63589216 |
| 100 | MP0005330_cardiomyopathy | 0.63440299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.70890982 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.37928510 |
| 3 | Vertebral compression fractures (HP:0002953) | 3.76205523 |
| 4 | Increased variability in muscle fiber diameter (HP:0003557) | 3.11683611 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 3.03701215 |
| 6 | Increased connective tissue (HP:0009025) | 3.01199002 |
| 7 | Upper limb amyotrophy (HP:0009129) | 2.95837937 |
| 8 | Distal upper limb amyotrophy (HP:0007149) | 2.95837937 |
| 9 | Fragile skin (HP:0001030) | 2.95366583 |
| 10 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.93831502 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 2.90185402 |
| 12 | Spinal rigidity (HP:0003306) | 2.83939826 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 2.81113672 |
| 14 | Achilles tendon contracture (HP:0001771) | 2.77336133 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.66227908 |
| 16 | Cervical subluxation (HP:0003308) | 2.64624540 |
| 17 | Obstructive sleep apnea (HP:0002870) | 2.63834471 |
| 18 | Cerebral aneurysm (HP:0004944) | 2.59496395 |
| 19 | Slender build (HP:0001533) | 2.59317938 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.56690582 |
| 21 | Hyperacusis (HP:0010780) | 2.55391930 |
| 22 | Vascular tortuosity (HP:0004948) | 2.52919568 |
| 23 | Ankle contracture (HP:0006466) | 2.52711781 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47332012 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47332012 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47332012 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 2.44227122 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42806181 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.41633693 |
| 30 | Nuclear cataract (HP:0100018) | 2.41374373 |
| 31 | Difficulty climbing stairs (HP:0003551) | 2.36631015 |
| 32 | Arterial tortuosity (HP:0005116) | 2.35747462 |
| 33 | Axonal loss (HP:0003447) | 2.35579905 |
| 34 | Aortic aneurysm (HP:0004942) | 2.32587598 |
| 35 | Atrophic scars (HP:0001075) | 2.32533766 |
| 36 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.30465428 |
| 37 | Blue sclerae (HP:0000592) | 2.28424289 |
| 38 | Hand muscle atrophy (HP:0009130) | 2.26411424 |
| 39 | Spondylolisthesis (HP:0003302) | 2.23663087 |
| 40 | Mitral regurgitation (HP:0001653) | 2.22932366 |
| 41 | Dilatation of the ascending aorta (HP:0005111) | 2.22169904 |
| 42 | Bladder diverticulum (HP:0000015) | 2.20587302 |
| 43 | Myopathic facies (HP:0002058) | 2.19129731 |
| 44 | Lower limb amyotrophy (HP:0007210) | 2.18741543 |
| 45 | Exercise-induced myalgia (HP:0003738) | 2.18013782 |
| 46 | Shallow orbits (HP:0000586) | 2.17007767 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.16578996 |
| 48 | Genu recurvatum (HP:0002816) | 2.16561385 |
| 49 | Insomnia (HP:0100785) | 2.15889716 |
| 50 | Wormian bones (HP:0002645) | 2.15462864 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.12104861 |
| 52 | Aortic dissection (HP:0002647) | 2.11015145 |
| 53 | Peritonitis (HP:0002586) | 2.10965909 |
| 54 | Broad face (HP:0000283) | 2.10473845 |
| 55 | Short nail (HP:0001799) | 2.09092600 |
| 56 | Cellulitis (HP:0100658) | 2.09010630 |
| 57 | Generalized amyotrophy (HP:0003700) | 2.08518464 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.06378804 |
| 59 | Biconcave vertebral bodies (HP:0004586) | 2.05847655 |
| 60 | Stridor (HP:0010307) | 1.99511050 |
| 61 | Joint stiffness (HP:0001387) | 1.99074050 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 1.98989041 |
| 63 | Abnormality of dentin (HP:0010299) | 1.97834603 |
| 64 | Broad metatarsal (HP:0001783) | 1.97299768 |
| 65 | Purpura (HP:0000979) | 1.95569395 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94480915 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94480915 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94480915 |
| 69 | Disproportionate tall stature (HP:0001519) | 1.92577939 |
| 70 | Aneurysm (HP:0002617) | 1.92330335 |
| 71 | Loss of speech (HP:0002371) | 1.91412615 |
| 72 | Mucopolysacchariduria (HP:0008155) | 1.90027041 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90027041 |
| 74 | Hypertensive crisis (HP:0100735) | 1.89858202 |
| 75 | Round ear (HP:0100830) | 1.89778003 |
| 76 | Polygenic inheritance (HP:0010982) | 1.86682646 |
| 77 | Hypoventilation (HP:0002791) | 1.83960070 |
| 78 | Polycythemia (HP:0001901) | 1.83319919 |
| 79 | Emphysema (HP:0002097) | 1.82622326 |
| 80 | Bulbar palsy (HP:0001283) | 1.80507236 |
| 81 | Hyperparathyroidism (HP:0000843) | 1.77185414 |
| 82 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76716173 |
| 83 | Eczematoid dermatitis (HP:0000976) | 1.76698544 |
| 84 | Muscle fiber splitting (HP:0003555) | 1.76443081 |
| 85 | Foot dorsiflexor weakness (HP:0009027) | 1.76244034 |
| 86 | Hyperextensible skin (HP:0000974) | 1.74950426 |
| 87 | Elbow flexion contracture (HP:0002987) | 1.74376643 |
| 88 | Petechiae (HP:0000967) | 1.73078936 |
| 89 | Amyloidosis (HP:0011034) | 1.72813946 |
| 90 | Ulnar bowing (HP:0003031) | 1.72035665 |
| 91 | Joint laxity (HP:0001388) | 1.71561124 |
| 92 | Coxa vara (HP:0002812) | 1.64978715 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 1.62042127 |
| 94 | Soft skin (HP:0000977) | 1.61778663 |
| 95 | Easy fatigability (HP:0003388) | 1.61671833 |
| 96 | Neonatal short-limb short stature (HP:0008921) | 1.61070973 |
| 97 | Abnormality of the nasal mucosa (HP:0000433) | 1.60486423 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 1.60078361 |
| 99 | Hyporeflexia of lower limbs (HP:0002600) | 1.59123488 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 1.58040844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.43233735 |
| 2 | MAP3K11 | 3.36789953 |
| 3 | TRIB3 | 3.17906637 |
| 4 | PRPF4B | 2.80647228 |
| 5 | IRAK3 | 2.52081606 |
| 6 | MAP2K3 | 2.42815516 |
| 7 | SIK1 | 2.30222352 |
| 8 | ICK | 2.07122530 |
| 9 | TAOK2 | 2.06310967 |
| 10 | TESK1 | 2.05276688 |
| 11 | SMG1 | 1.94412121 |
| 12 | NME2 | 1.90717030 |
| 13 | RIPK1 | 1.89942436 |
| 14 | TTN | 1.88226536 |
| 15 | EPHA2 | 1.78965298 |
| 16 | ARAF | 1.78791587 |
| 17 | PRKD2 | 1.78013464 |
| 18 | EPHB1 | 1.70347020 |
| 19 | PAK4 | 1.66361273 |
| 20 | MAP3K13 | 1.62966283 |
| 21 | RIPK4 | 1.60448595 |
| 22 | TAOK1 | 1.60074217 |
| 23 | MAP3K3 | 1.58004671 |
| 24 | MAP4K1 | 1.57948216 |
| 25 | PRKD3 | 1.51692474 |
| 26 | MAP3K1 | 1.50255116 |
| 27 | MOS | 1.44338892 |
| 28 | MARK2 | 1.32885843 |
| 29 | PIM2 | 1.32297622 |
| 30 | PTK2 | 1.32227422 |
| 31 | TESK2 | 1.26475376 |
| 32 | PDGFRA | 1.26332824 |
| 33 | PAK6 | 1.25740825 |
| 34 | TBK1 | 1.23256978 |
| 35 | STK38 | 1.16521809 |
| 36 | KSR2 | 1.15900577 |
| 37 | NTRK1 | 1.13062406 |
| 38 | DDR2 | 1.07286889 |
| 39 | LIMK1 | 1.03626921 |
| 40 | IRAK4 | 1.02280733 |
| 41 | DYRK1B | 1.00668530 |
| 42 | MST1R | 0.96407629 |
| 43 | BRAF | 0.95912820 |
| 44 | BMX | 0.93363561 |
| 45 | PDPK1 | 0.92777035 |
| 46 | CDC42BPA | 0.91703474 |
| 47 | TGFBR2 | 0.91511223 |
| 48 | LATS2 | 0.90446266 |
| 49 | TNK2 | 0.89223801 |
| 50 | PRKG2 | 0.88973082 |
| 51 | LMTK2 | 0.88729354 |
| 52 | SIK2 | 0.86837423 |
| 53 | PTK6 | 0.85196574 |
| 54 | TYK2 | 0.81310837 |
| 55 | SIK3 | 0.80867652 |
| 56 | MYLK | 0.78347276 |
| 57 | MAPK12 | 0.78033858 |
| 58 | ABL2 | 0.76892901 |
| 59 | ZAP70 | 0.76874043 |
| 60 | IRAK2 | 0.75954159 |
| 61 | DAPK3 | 0.72028897 |
| 62 | PKN2 | 0.68932157 |
| 63 | RPS6KA2 | 0.68833939 |
| 64 | JAK3 | 0.68764857 |
| 65 | EPHB2 | 0.66419133 |
| 66 | MAP3K9 | 0.65938812 |
| 67 | HIPK2 | 0.65764537 |
| 68 | SCYL2 | 0.63423024 |
| 69 | MAP3K8 | 0.61314708 |
| 70 | CSK | 0.57974504 |
| 71 | PAK2 | 0.57667331 |
| 72 | MTOR | 0.57104862 |
| 73 | PDK1 | 0.55044990 |
| 74 | MAP3K7 | 0.54401003 |
| 75 | DMPK | 0.52796784 |
| 76 | LRRK2 | 0.52647751 |
| 77 | ROCK2 | 0.52381900 |
| 78 | PAK1 | 0.51835272 |
| 79 | ILK | 0.51095406 |
| 80 | PTK2B | 0.50864742 |
| 81 | DAPK1 | 0.49933635 |
| 82 | PHKG2 | 0.49656120 |
| 83 | PHKG1 | 0.49656120 |
| 84 | FGFR4 | 0.48948480 |
| 85 | GRK5 | 0.48846170 |
| 86 | DAPK2 | 0.48732921 |
| 87 | RPS6KC1 | 0.47543432 |
| 88 | RPS6KL1 | 0.47543432 |
| 89 | PRKCH | 0.47057220 |
| 90 | FES | 0.46650373 |
| 91 | MAPK7 | 0.46432444 |
| 92 | CDK12 | 0.44946977 |
| 93 | MAP3K6 | 0.44398283 |
| 94 | RAF1 | 0.41300570 |
| 95 | CAMK2G | 0.39056623 |
| 96 | CAMKK1 | 0.39003477 |
| 97 | MAP3K14 | 0.38559807 |
| 98 | CDK11A | 0.37755455 |
| 99 | MAP3K12 | 0.37226842 |
| 100 | GRK6 | 0.37016070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.62930178 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.56973579 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80834942 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76297679 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71758577 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.65891893 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62177038 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58016488 |
| 9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.56646475 |
| 10 | Prion diseases_Homo sapiens_hsa05020 | 1.56576379 |
| 11 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.48731186 |
| 12 | Bladder cancer_Homo sapiens_hsa05219 | 1.48132888 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44414995 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42063371 |
| 15 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41049346 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39845969 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38616207 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.37266894 |
| 19 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36031288 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.34822382 |
| 21 | Focal adhesion_Homo sapiens_hsa04510 | 1.33750065 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32756842 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.30746874 |
| 24 | Endocytosis_Homo sapiens_hsa04144 | 1.29079795 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27145536 |
| 26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22898452 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20597845 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19419812 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19401452 |
| 30 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.17421795 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16668357 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.14957258 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.14456069 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.13620940 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12675477 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.12518514 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.11423938 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09873498 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09024119 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06789825 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03945594 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03078196 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02086637 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01174369 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.01049483 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00493143 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00032636 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99881020 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99063840 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99037485 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93653375 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92600249 |
| 53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91596019 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.91524145 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90517661 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90501876 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90465796 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89436763 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.88951806 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87457987 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.86317613 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81416719 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80131253 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.79197867 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.78476188 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.78315559 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76958879 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76879120 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76354084 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74023212 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73084544 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72232897 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72159177 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71494150 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.70888962 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68495300 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66876031 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66723963 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66680196 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64662861 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64186788 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.63645148 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63145168 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62123332 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61954803 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61663014 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61408346 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61248336 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60536507 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59253832 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59102248 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59050606 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57441118 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55894220 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.54075382 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52773596 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50039798 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.49504400 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47956019 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.46642482 |

